Rick (R) Kapur MD PhD
Training
Biology/Biomedical Sciences (BSc, MSc), Medicine (MD), Immunohematology (PhD)
Thesis
Multifactorial aspects of antibody‐mediated blood cell destruction
University of Amsterdam, Amsterdam, March 18, 2014
Research interests
Dissection of pathophysiological mechanisms in Transfusion Medicine, with focus on Transfusion-related acute lung injury (TRALI), antibody-mediated hematological disorders including immune thrombocytopenia (ITP), fetal and neonatal alloimmune thrombocytopenia (FNAIT), hemolytic disease of the fetus and newborn (HDFN). Additional interests include immune functions of platelets.
Technologies: experimental mouse models, diverse immunological assays including phagocytosis and respiratory burst assays.
Resume
|
2019 - present |
Researcher at Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands |
|
2017 - 2019 |
Post-doctoral fellow at Lund University, Lund, Sweden. |
|
2015 - 2017 |
Post-doctoral fellow at Canadian Blood Services, Toronto Platelet Immunobiology Group, Keenan Research Center for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada. |
|
2009-2014 |
PhD at Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Thesis: “Multifactorial Aspects of Antibody-Mediated Blood Cell Destruction”. Supervisor: Prof. Dr. C.E. van der Schoot. Co-supervisor: Dr. G. Vidarsson. |
|
2004-2008 |
MD at SUMMA (Selective Utrecht Medical Masters), University Medical Center Utrecht, Utrecht University, The Netherlands. |
|
1998-2004 |
BSc and MSc in Biology with specialization in Fundamental Biomedical Sciences, Faculty of Biology, Utrecht University, The Netherlands. |
